EXAGEN INC. Amortization of Intangible Assets
EXAGEN INC. (XGN) reported Amortization of Intangible Assets of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2020-03-25
- EXAGEN INC. amortization of intangible assets for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- EXAGEN INC. amortization of intangible assets for fiscal 2018 was $141.00K.
| Period end | Amortization of Intangible Assets 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-25 |
| 2018-12-31 | $141.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |